Gritstone

YTD

ALL

Why Robinhood?

You can watch Gritstone and buy or sell other stocks, ETFs, and their options commission-free!

About GRTSQ

Gritstone bio, Inc. clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was founded by Andrew Allen, Timothy Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria in August 2015 and is headquartered in Emeryville, CA.

CEO

Vassiliki Celia Economides

CEOVassiliki Celia Economides

Employees

—

Employees—

Headquarters

Emeryville, California

HeadquartersEmeryville, California

Founded

2015

Founded2015

Employees

—

Employees—

GRTSQ Key Statistics

Market cap

100.00

Market cap100.00

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

6.03K

Average volume6.03K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$1.05

52 Week high$1.05

52 Week low

—

52 Week low—

Stock Snapshot

As of today, Gritstone(GRTSQ) shares are valued at $0.00. The company's market cap stands at 100.

On 2025-12-11, Gritstone(GRTSQ) shares started trading at —, with intraday highs of — and lows of —.

Trading volume for Gritstone(GRTSQ) stock has reached 0, versus its average volume of 6.03K.

People also own

Based on the portfolios of people who own GRTSQ. This list is generated using Robinhood data, and it’s not a recommendation.